Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Jul 13:14:1245809.
doi: 10.3389/fphar.2023.1245809. eCollection 2023.

Editorial: Recent trends and spotlight on nucleotide-based drugs: novel targets, their design, delivery, and clinical potential

Subhash Chander  1 , Shvetank Bhatt  2 , Kamal Dua  3   4   5 , Hemant Jadhav  6
Affiliations
Editorial

Editorial: Recent trends and spotlight on nucleotide-based drugs: novel targets, their design, delivery, and clinical potential

Subhash Chander et al. Front Pharmacol. .
No abstract available

Keywords: Parkinson; nasal delivery; nucleotide; oligonucleotide; pharmacokinetic; targeted delivery.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Comment on

  • Editorial on the Research Topic Recent trends and spotlight on nucleotide-based drugs: novel targets, their design, delivery, and clinical potential

References

    1. Garner A. L. (2021). Nucleosides, nucleotides and nucleic acids as therapeutics: A virtual special issue. ACS Pharmacol. Transl. Sci. 4 (6), 1714–1715. 10.1021/acsptsci.1c00231 - DOI - PMC - PubMed
    1. Igarashi J., Niwa Y., Sugiyama D. (2022). Research and development of oligonucleotide therapeutics in Japan for rare diseases. Future Rare Dis. 2 (1), 1–13. 10.2217/frd-2021-0008 - DOI
    1. Moumné L., Marie A. C., Crouvezier N. (2022). Oligonucleotide therapeutics: From Discovery and development to patentability. Pharmaceutics 14 (2), 260. 10.3390/pharmaceutics14020260 - DOI - PMC - PubMed
    1. Roberts T. C., Langer R., Wood M. J. A. (2020). Advances in oligonucleotide drug delivery. Nat. Rev. Drug Discov. 19, 673–694. 10.1038/s41573-020-0075-7 - DOI - PMC - PubMed
    1. Sridharan K., Gogtay N. J. (2016). Therapeutic nucleic acids: Current clinical status. Br. J. Clin. Pharmacol. 82 (3), 659–672. 10.1111/bcp.12987 - DOI - PMC - PubMed

Publication types

LinkOut - more resources